Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Medtronic
Johnson and Johnson
AstraZeneca
UBS
Cerilliant
QuintilesIMS
Teva
Queensland Health

Generated: August 15, 2018

DrugPatentWatch Database Preview

GLYSET Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Glyset, and what generic alternatives are available?

Glyset is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in GLYSET is miglitol. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the miglitol profile page.

Drug patent expirations by year for GLYSET
Pharmacology for GLYSET
Synonyms for GLYSET
(2R,3R,4R,5S)-1-(2-Hydroxyethyl)-2-(2-hydroxymethyl)-3,4,5-piperidinetriol
(2R,3R,4R,5S)-1-(2-Hydroxyethyl)-2-(hydroxymethyl)-3,4,5-piperidinetriol
(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol
(2R,3R,4R,5S)-1-ethoxy-2-(hydroxymethyl)piperidine-3,4,5-triol
(2R,3R,4R)-1-(2-Hydroxyethyl)-2-(hydroxymethyl)-piperidine-3,4-diol
0V5436JAQW
1-?(2-?HYDROXYETHYL)-?2R-?(HYDROXYMETHYL)-?3R,?4R,?5S-?PIPERIDINETRIOL
1,5-Dideoxy-1,5-((2-hydroxyethyl)imino)-D-glucitol
1,5-dideoxy-1,5-[(2-hydroxyethyl)imino]-D-glucitol
3,4,5-Piperidinetriol, 1-(2-hydroxyethyl)-2-(hydroxymethyl)-, (2R-(2alpha,3beta,4alpha,5beta))-
432M032
72432-03-2
A837526
AB0014109
AB00639982_08
AB00639982-06
AB2000682
AC1L9AYD
ACN-040712
AKOS015969689
AOB5559
Bay 1099
Bay m 1099
Bay m1009
Bay-m-1099
baym1099
BDBM50242271
BIDD:GT0732
Bio-0159
C07708
C8H17NO5
CAS-72432-03-2
CCG-100920
CHEBI:6935
CHEMBL1561
cid_441314
CPD000466381
CS-2596
CTK8G1117
D00625
D0D0ZD
DB00491
Diastabol
DR000347
DSSTox_CID_3323
DSSTox_GSID_23323
DSSTox_RID_76977
DTXSID0023323
EINECS 276-661-6
FT-0628946
Glyset (TN)
GTPL4842
HE284684
HE383387
HMS2051D05
HSDB 8022
HY-B0481
K230
KS-1242
M2302
MCULE-2158237443
MFCD00867240
MIGLITOL
Miglitol (Glyset)
Miglitol (JAN/USAN/INN)
Miglitol (JP17/USAN/INN)
Miglitol [USAN:INN:BAN]
Miglitolum
Miglitolum [Latin]
MLS000759514
MLS001424128
MLS006011963
MolPort-006-069-197
N-(2-Hydroxyethyl)-1-deoxynojirimycin
N-(b-Hydroxyethyl)-1-deoxynojirimycin
N-hydroxylethyl-1-deoxynojirimycin
NC00170
NCGC00095127-01
NCGC00270540-02
NE45506
Plumarol
PubChem21444
PubChem6069
RL04761
S2589
SAM001246745
SC-02811
SCHEMBL22593
Seibule
SK-983
SMR000466381
SYN3027
Tox21_111436
Tox21_111436_1
UNII-0V5436JAQW
W-104490
Z1541638520
ZINC4097426

US Patents and Regulatory Information for GLYSET

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-001 Dec 18, 1996 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-002 Dec 18, 1996 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-003 Dec 18, 1996 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for GLYSET

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-001 Dec 18, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-003 Dec 18, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-002 Dec 18, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Daiichi Sankyo
US Department of Justice
Queensland Health
Johnson and Johnson
Chinese Patent Office
McKesson
Dow
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.